Inspiralia
J. Craig Hartman is an accomplished professional with extensive experience in consulting and leadership roles within the pharmaceutical and biotechnology sectors. Currently serving as a Grant Reviewer for Inspiralia and as a Consultant for several organizations including Freyr Solutions, MILLENDO THERAPEUTICS, CYLERUS, INC., and Perfuse Therapeutics, J. Craig Hartman also holds advisory and vice president positions at AdvisoryCloud, MDI Therapeutics, Inc., and Revivo Therapeutics. J. Craig Hartman's educational background includes a Ph.D. in Pharmacology and Toxicology from the Medical College of Wisconsin and a BS in Biology and Chemistry from Purdue University.
This person is not in any offices
Inspiralia
Inspiralia Group is an international New Product Development company founded in 2005 that operates in almost 30 countries worldwide. Our mission is to support our clients to develop and market innovative products. To accomplish that, we offer a complete 360-degree service. From concept generation and innovation strategy through to product development and market launch, Inspiralia helps companies with their global product launch.